{"id":476929,"date":"2021-04-15T08:48:06","date_gmt":"2021-04-15T12:48:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/"},"modified":"2021-04-15T08:48:06","modified_gmt":"2021-04-15T12:48:06","slug":"skye-bioscience-to-present-at-upcoming-investment-conferences-in-april","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/","title":{"rendered":"Skye Bioscience to Present at Upcoming Investment Conferences in April"},"content":{"rendered":"
\n

San Diego, Calif, April 15, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (\u201cSKYE\u201d or the \u201cCompany\u201d), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, announced today that Punit Dhillon, CEO, Skye\u00a0Bioscience will present a virtual corporate overview at the Sequire Cannabis Investor Conference and Planet Microcap Showcase next week. Details are as follows:<\/p>\n

\n
\n Sequire Cannabis Investor Conference <\/u>
\n <\/strong>
\n
\n Date:<\/strong> April 20, 2021
Time: <\/strong>12:30 PM EST; Track 1
Registration Link:\u00a0<\/strong>https:\/\/bit.ly\/3aeOPi2<\/u><\/a><\/p>\n

\n
\n Planet Microcap Showcase <\/u>
\n <\/strong>
\n
\n Date: <\/strong>April 22, 2021
Time: <\/strong>10:30 AM EST; Track 1
Registration Link:\u00a0<\/strong>https:\/\/bit.ly\/3mLO9pa<\/u><\/a><\/p>\n

\n About Skye Bioscience, Inc. <\/strong>
\n
Skye Bioscience Inc. is a biopharmaceutical company unlocking the pharmaceutical potential of cannabinoids through the development of its proprietary, cannabinoid-derived molecules to treat diseases with significant unmet needs. The company\u2019s lead molecule, in preclinical studies, has demonstrated potential as a new class of therapy to lower intraocular pressure in patients with glaucoma or elevated intraocular pressure that is superior to the current standard of care. For more information, please visit: www.skyebioscience.com<\/u><\/a>. <\/u><\/p>\n

\n CONTACT<\/strong>
\n
Karam Takhar
VP, Corporate Development & Investor Relations
Email: ir@skyebioscience.com<\/u><\/a>
Phone: (858) 410-0266<\/p>\n

\n FORWARD LOOKING STATEMENTS <\/strong>
\n
This press release contains forward-looking statements, including statements regarding our product development, business strategy, timing of clinical trials and commercialization of cannabinoid-derived therapeutics. Such statements and other statements in this press release that are not descriptions of historical facts are forward-looking statements that are based on management\u2019s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition, and stock price could be materially negatively affected. In some cases, forward-looking statements can be identified by terminology including \u201canticipated,\u201d \u201ccontemplates,\u201d \u201cgoal,\u201d \u201cfocus,\u201d \u201caims,\u201d \u201cintends,\u201d \u201cbelieves,\u201d \u201ccan,\u201d \u201ccould,\u201d \u201cchallenge,\u201d \u201cpredictable,\u201d \u201cwill,\u201d \u201cwould,\u201d \u201cmay\u201d or the negative of these terms or other comparable terminology. We operate in a rapidly changing environment and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make. Risks and uncertainties that may cause actual results to differ materially include, among others, our capital resources, uncertainty regarding the results of future testing and development efforts and other risks that are described in the Risk Factors section of Skye\u2019s most recent annual or quarterly report filed with the Securities and Exchange Commission. Except as expressly required by law, Skye disclaims any intent or obligation to update these forward-looking statements.<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

San Diego, Calif, April 15, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (\u201cSKYE\u201d or the \u201cCompany\u201d), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, announced today that Punit Dhillon, CEO, Skye\u00a0Bioscience will present a virtual corporate overview at the Sequire Cannabis Investor Conference and Planet Microcap Showcase next week. Details are as follows: Sequire Cannabis Investor Conference Date: April 20, 2021Time: 12:30 PM EST; Track 1 Registration Link:\u00a0https:\/\/bit.ly\/3aeOPi2 Planet Microcap Showcase Date: April 22, 2021Time: 10:30 AM EST; Track 1 Registration Link:\u00a0https:\/\/bit.ly\/3mLO9pa About Skye Bioscience, Inc. Skye Bioscience Inc. is a biopharmaceutical company unlocking the pharmaceutical potential of cannabinoids through the development of its proprietary, cannabinoid-derived molecules to … <\/p>\n

Continue reading “Skye Bioscience to Present at Upcoming Investment Conferences in April”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-476929","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSkye Bioscience to Present at Upcoming Investment Conferences in April - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Skye Bioscience to Present at Upcoming Investment Conferences in April - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"San Diego, Calif, April 15, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (\u201cSKYE\u201d or the \u201cCompany\u201d), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, announced today that Punit Dhillon, CEO, Skye\u00a0Bioscience will present a virtual corporate overview at the Sequire Cannabis Investor Conference and Planet Microcap Showcase next week. Details are as follows: Sequire Cannabis Investor Conference Date: April 20, 2021Time: 12:30 PM EST; Track 1 Registration Link:\u00a0https:\/\/bit.ly\/3aeOPi2 Planet Microcap Showcase Date: April 22, 2021Time: 10:30 AM EST; Track 1 Registration Link:\u00a0https:\/\/bit.ly\/3mLO9pa About Skye Bioscience, Inc. Skye Bioscience Inc. is a biopharmaceutical company unlocking the pharmaceutical potential of cannabinoids through the development of its proprietary, cannabinoid-derived molecules to … Continue reading "Skye Bioscience to Present at Upcoming Investment Conferences in April"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-15T12:48:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Skye Bioscience to Present at Upcoming Investment Conferences in April\",\"datePublished\":\"2021-04-15T12:48:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/\"},\"wordCount\":462,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/\",\"name\":\"Skye Bioscience to Present at Upcoming Investment Conferences in April - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng==\",\"datePublished\":\"2021-04-15T12:48:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Skye Bioscience to Present at Upcoming Investment Conferences in April\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Skye Bioscience to Present at Upcoming Investment Conferences in April - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/","og_locale":"en_US","og_type":"article","og_title":"Skye Bioscience to Present at Upcoming Investment Conferences in April - Market Newsdesk","og_description":"San Diego, Calif, April 15, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (\u201cSKYE\u201d or the \u201cCompany\u201d), a biopharmaceutical company developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, announced today that Punit Dhillon, CEO, Skye\u00a0Bioscience will present a virtual corporate overview at the Sequire Cannabis Investor Conference and Planet Microcap Showcase next week. Details are as follows: Sequire Cannabis Investor Conference Date: April 20, 2021Time: 12:30 PM EST; Track 1 Registration Link:\u00a0https:\/\/bit.ly\/3aeOPi2 Planet Microcap Showcase Date: April 22, 2021Time: 10:30 AM EST; Track 1 Registration Link:\u00a0https:\/\/bit.ly\/3mLO9pa About Skye Bioscience, Inc. Skye Bioscience Inc. is a biopharmaceutical company unlocking the pharmaceutical potential of cannabinoids through the development of its proprietary, cannabinoid-derived molecules to … Continue reading \"Skye Bioscience to Present at Upcoming Investment Conferences in April\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-15T12:48:06+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Skye Bioscience to Present at Upcoming Investment Conferences in April","datePublished":"2021-04-15T12:48:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/"},"wordCount":462,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/","name":"Skye Bioscience to Present at Upcoming Investment Conferences in April - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng==","datePublished":"2021-04-15T12:48:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxNzczNiM0MTIzMDUwIzUwMDA3MDk1Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/skye-bioscience-to-present-at-upcoming-investment-conferences-in-april\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Skye Bioscience to Present at Upcoming Investment Conferences in April"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476929","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=476929"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/476929\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=476929"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=476929"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=476929"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}